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The Golgi complex plays a key role in the processing and sorting of polypeptides that enter the exocytic pathway. This organelle consists of stacks of flattened cisternae that can be divided into at least three functionally distinct subcompartments: cis, middle, and trans (1) (2) (3) . Each subcompartment is enriched in different glycosidases, glycosyltransferases, and other processing enzymes (4) . This compartmentalization allows orderly and sequential processing of glycoproteins as they are transported vectorially through the Golgi (4) . Little is known regarding the mechanism by which resident Golgi proteins are sorted from those that will reach the plasma membrane and how those resident proteins are retained in specific Golgi cisternae.
It was shown previously that the El glycoprotein of an avian coronavirus, infectious bronchitis virus (IBV), is targeted to the Golgi region of cells expressing the protein from cloned cDNA (5) . Here we have used immunoperoxidase and immunogold labeling in conjunction with analysis of carbohydrate processing to determine the specific site [i.e., transitional elements of the endoplasmic reticulum (ER) or subcompartment of the Golgi] to which the El glycoprotein is targeted. We report that the El glycoprotein is concentrated in the cis Golgi of cells expressing the protein from cloned cDNA.
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MATERIALS AND METHODS
Cells and Viruses. AtT-20 and COS-1 cells were maintained in Dulbecco's modified Eagle's medium with 5% fetal bovine serum. The generation of recombinant vaccinia viruses encoding the wild-type El protein and the mutant Aml,2 was previously described (5) .
Anti-El Antibody. The polyclonal antibody recognizing the IBV El protein was generated in a rabbit immunized with a synthetic peptide corresponding to the 22 carboxyl-terminal amino acids of El and affinity purified as described (5) .
Immunoperoxidase Labeling. AtT-20 cells were plated in 35-mm dishes 2 days prior to infection. Cells that were about 80% confluent were infected with recombinant vaccinia viruses at a multiplicity of infection of -20, with adsorption of 0.25 ml of serum-free medium for 30 min at 37QC. Medium containing serum was then added, and cells were fixed at 4 hr after infection in 3% paraformaldehyde/0.05% glutaraldehyde in phosphate buffer for 1 hr at room temperature. Labeling was carried out in the tissue culture dish as described (6) . In brief, cells were permeabilized with 0.05% saponin in phosphate-buffered saline and then incubated sequentially with affinity-purified anti-El IgG (1:40 for 2 hr) and Fab fragments of sheep anti-rabbit IgG conjugated to horseradish peroxidase (1:50 for 2 hr), after which they were aldehyde fixed, allowed to react with diaminobenzidine, and processed for electron microscopy.
Immunogold Labeling. Cells were plated, infected, and fixed as described above, except that 100-mm dishes were used; the cells were fixed for 1 hr after which they were collected and processed for cryoultramicrotomy (7) and immunogold labeling as described (8, 9) . Ultrathin cryosections were incubated in affinity-purified anti-El antibody (diluted 1:40 for 1 hr), followed by goat anti-rabbit IgG conjugated to 5-nm colloidal gold (diluted 1:50 for 1 hr). They were stained sequentially with 2% OS04 (15 min), 2% acidic uranyl acetate (15 min), and 0.002% lead citrate in 2.2% polyvinyl alcohol (5 min) (7) .
Immunofluorescence. Semithin cryosections (0.5-1 gm) were incubated with affinity-purified anti-El antibody (1:50 for 2 hr), followed by rhodamine-conjugated sheep antirabbit F(ab')2 (1:50 for 1 hr), mounted, and photographed as described (9) . Proc. Natl. Acad. Sci. USA 87 (1990) 6945 (5) . For glycosidase digestion, immunoprecipitates were eluted from the Staphylococcus aureus pellets in 10 mM Tris, pH 8.6/0.5% SDS/0.1% 2-mercaptoethanol by incubation at 100?C for 2 min. The sample was split into three aliquots and either left untreated or digested with endoglycosidase (Endo H) (0.2 milliunit) or N-glycanase (0.05 milliunit) in a volume of 20 ,ul for 16 hr at 37?C as described (10) . After addition of 6 ,lI of 4x sample buffer containing 2% 2-mercaptoethanol, samples were electrophoresed in 15% polyacrylamide gels and fluorographed.
RESULTS By indirect immunofluorescence it was previously demonstrated that the El protein is expressed in the juxtanuclear or Golgi region of transfected COS-1 cells (5) . To determine the precise localization of El among the multiple organelles found in the Golgi region, we explored several transient expression systems and found that use of recombinant vaccinia viruses was best for this purpose, since virtually all of the cells on a culture dish could be infected and expressed El at a high level. COS-1 cells were used in earlier experiments, but they have the disadvantage that their Golgi is small and its polarity is difficult to determine. Subsequently we turned to the murine anterior pituitary AtT-20 cell line, since these cells contain secretion granules (8) , and the polarity of the Golgi can be determined morphologically by the presence of secretory granules marking the trans side of the stacks (11) . When the wild-type and Aml,2 mutant proteins were localized by indirect immunofluorescence in AtT-20 cells infected with recombinant vaccinia viruses, wild-type El was concentrated in the juxtanuclear region ( Fig. 1A) , whereas the mutant El protein was localized mainly to the plasma membrane ( Fig. 1B) . Thus, the distribution of El expressed in AtT-20 cells using a recombinant vaccinia virus was similar at the light microscope level to that observed earlier in COS cells using a simian virus 40 vector except that the number of cells expressing the El protein was much higher (>90%). No viral cytopathic effects were seen at early times (4 hr) after infection of COS cells or AtT-20 cells with the recombinant vaccinia viruses. ing of COS and AtT-20 cells with an affinity-purified anti-El antibody, peroxidase reaction product was found in the cytoplasm associated with the outer surface of one or two cisternae on one side of the Golgi stack (Fig. 2) . The sidedness of the stack could not be reliably determined in COS cells; however, in AtT-20 cells the labeled cisternae could be identified as cis cisternae, based on the fact that they were situated on the opposite side of the stack from secretory granules. By definition (2, 3) , secretory granules are found on the trans side of the stack (arrow, Fig. 2 B and C) . The location of the reaction product in the cytoplasm, along side the cis cisternae, is in keeping with the fact that the antibody recognizes the cytoplasmic domain of El, as it was raised against a synthetic peptide corresponding to its 22 carboxyl-terminal amino acids. Occasionally, peroxidase reaction product was also seen in association with ER cisternae.
To verify the immunoperoxidase results, we performed immunogold localizations on ultrathin cryosections prepared from AtT-20 cells infected with the recombinant vaccinia virus encoding El as described above. In cells fixed 4 hr after infection, gold particles were again found in close association with one or two of the cis-most cisternae of the Golgi stacks ( Fig. 3) , with vesicles on the cis side, and occasionally with ER cisternae. This labeling pattern was unchanged when cells were incubated an additional 2 hr in the presence of cycloheximide to prevent protein synthesis and to allow time for transport of El to its final destination. Thus by immunogold and immunoperoxidase methods El expression was confined to cis cistemae and was not detected in middle or trans cisternae.
We next localized the mutant El protein that lacks the first and second of three membrane-spanning domains. In contrast to the wild-type protein, this protein is transported to the plasma membrane as determined by indirect immunofluorescence ( Fig. 1 ) and susceptibility to exogenously added protease (5) . We reasoned that at early times after infection we should be able to detect the protein in transit through the Golgi cisternae as well as at the plasma membrane. In AtT-20 cells fixed 4 hr after infection with the mutant protein, gold particles were distributed across the entire Golgi stack as well as on the plasma membrane (not shown). Thus, whereas the wild-type El protein accumulated at a specific site (cis cisternae) in the Golgi complex, the mutant protein apparently had no such constraints on its movement.
Wild-Type El Protein Contains Incompletely Processed N-Linked Oligosaccharides. The El protein of the avian coronavirus IBV has two N-asparagine-linked oligosaccharides near its amino terminus (12, 13) . We analyzed the processing of these oligosaccharides in cells expressing wild-type El from a recombinant vaccinia virus after biosynthetic labeling with [35S]cysteine from 2 until 4 hr after infection. When El proteins were immunoprecipitated from detergent lysates of AtT-20 cells, the majority of the wild-type El protein remained Endo H sensitive during the labeling period, although about 20% was processed to a resistant form (Fig. 4, lanes  1-3) . The fraction that was Endo H resistant was found to be somewhat variable in different experiments. Less than 5% of the wild-type El protein synthesized in COS cells was processed under identical labeling conditions (Fig. 4, lanes  7-9) . These results indicate that most of the El glycoprotein has not been acted on by the middle Golgi enzymes amannosidase II and GlcNAc transferase I, which convey Endo H resistance. The reaction product is located in the cytoplasm adjacent to the cis cisternae, which is in keeping with the fact that the antibody recognizes the carboxyl-terminal cytoplasmic domain of El. Iy, Lysosome; nu, nucleus. (A, x15,O00; B, x32,O00; C, x38,000.) 60% became resistant in COS cells during the 2-hr labeling period. In immunoprecipitates from cells expressing Aml,2 the Endo H-resistant material appeared as a broad band (Fig.  4, lanes 4 and 5 and lanes 10 and 11) . However a discrete band was obtained after N-glycanase digestion (Fig. 4, lanes 6 and  12) , indicating that the heterogeneity was due to the presence of N-linked oligosaccharides. The size heterogeneity of the Endo H-resistant material resembled that described for several other membrane proteins with polylactosaminoglycan type N-linked oligosaccharides (10, 14, 15) . The heterogeneous, Endo H-resistant form of Aml,2 bound immobilized tomato lectin (Lycopersicon esculentum) and Datura stramonium lectin (not shown), providing further evidence that this modification was polylactosaminoglycan (16, 17) . Although the enzymes involved in this modification have not been purified or localized, they are assumed to be located in the middle or trans subcompartments of the Golgi complex (14) . 
DISCUSSION
The data presented in this paper demonstrate that the El protein from the avian coronavirus is retained in cis Golgi cisternae when expressed from cloned cDNA in animal cells. Earlier work using indirect immunofluorescence microscopy suggested targeting to elements in the Golgi region, but the specific site of targeting could not be determined. To precisely localize the El glycoprotein among the numerous organelles found in the Golgi region, we utilized immunoperoxidase and immunogold labeling at the electron microscope level. Use of recombinant vaccinia virus vectors has a distinct advantage for this type of analysis since a high level of expression is obtained in >90% of the cells early after infection. We found that the El protein accumulated in the first one or two cisternae of the Golgi stack. The extent of processing of the N-linked oligosaccharides on El was consistent with this localization, as the majority of El expressed in AtT-20 cells was Endo H sensitive, although a fraction (about 20%) was processed to an Endo H-resistant form. In COS cells, the fraction of processed oligosaccharides was <5%. Processing to an Endo H-resistant form occurs with the addition of the first GlcNAc residue to the trimmed core oligosaccharide and removal of one of the five remaining mannose residues (4). This is believed to occur in the middle (medial) Golgi cisternae, as N-acetylglucosamine transferase I has been localized to this region of the Golgi (1) . The fact that some processing of El occurs even though it is concentrated on the cis side of the Golgi suggests that there is some overlap in its distribution with GlcNAc transferase I.
The results obtained with a mutant El protein called Aml,2, which lacks the first and second of the three El membrane-spanning domains, were quite different. Early after initiating expression of Aml,2, it could be observed in all cisternae throughout the Golgi stack as well as at the plasma membrane. In addition, the oligosaccharides were efficiently processed to an Endo H-resistant form. Thus, in contrast to the wild-type protein, there was no block in transport of the mutant protein along the exocytic pathway. The heterogeneity and lectin-binding properties of its processed oligosaccharides suggested they were of the polylactosaminoglycan type (10, 14) . This particular processing occurred on the mutant El protein as it was transported through the Golgi en route to the plasma membrane.
The simplest interpretation of our results is that the IBV El protein possesses a signal for retention in the cis region of the Golgi complex. The protein was efficiently transported out of the ER but stopped when it reached the first few Golgi cisternae. In contrast, the mutant protein apparently lacks this retention signal and was transported through the Golgi complex to the plasma membrane. The retention signal may reside in the part of the polypeptide that has been deleted or may be in another region but structurally disrupted by the deletion. Further work is necessary to define the molecular nature of this retention signal.
The intracellular site of budding of IBV has not been investigated in detail. However, considerable work has been done with another coronavirus, mouse hepatitis virus (MHV). In most MHV-infected cell lines examined, the major site of budding is a pre-Golgi compartment termed the transitional or intermediate compartment (18, 19) . However, some budding occurs in the Golgi complex in MHV-infected AtT-20 cells (20) . By indirect immunofluorescence MHV El was also found to be localized in the Golgi region of several different cell lines expressing the protein from cloned cDNA (21) (22) (23) . Its precise localization among Golgi elements has not yet been investigated.
Recently cDNA clones encoding several endogenous trans Golgi glycosyltransferases have been isolated. These include f3-1,4-galactosyltransferase (24-27), a-1,3-galactosyltransferase (28, 29) , a-2,6-sialyltransferase (30), and a-1,2-fucosyltransferase (31) . A partial clone encoding a middle Golgi enzyme, a-mannosidase II, has also been reported (32) . Although several proteins resident in the cis Golgi have been identified (33, 34) , no cDNAs encoding endogenous cis Golgi proteins are yet available. Thus the avian IBV coronavirus El protein should prove to be a useful marker for the cis region of the Golgi complex. In addition, the availability of mutant El proteins that are not retained in the Golgi may provide insight into the mechanisms of intracellular protein traffic through this organelle.
